7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials

This publication has 27 references indexed in Scilit:

• DNA topoisomerase I and II in cancer chemotherapy: update and perspectives
  Cancer Chemotherapy and Pharmacology, 1993
• Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line
  Biochemical and Biophysical Research Communications, 1992
• Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion
  JNCI Journal of the National Cancer Institute, 1992
• Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Detection of Proteins that Recognize Platinum-modified DNA Using Gel Mobility Shift Assay
  Japanese Journal of Cancer Research, 1990
• Characterization of an etoposide-resistant human small-cell lung cancer cell line
  Cancer Chemotherapy and Pharmacology, 1990
• Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines.
  Journal of Biological Chemistry, 1990
• LEVELS OF GLUTATHIONES TRANSFERASE π mRNA IN HUMAN LUNG CANCER CELL LINES CORRELATE WITH THE RESISTANCE TO CISPLATIN AND CARBOPLATIN
  Japanese Journal of Cancer Research, 1988
• Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
  Proceedings of the National Academy of Sciences, 1987
• Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei.
  Proceedings of the National Academy of Sciences, 1981